The Program for Innovative Therapeutics in Chest and Esophago-Gastric Cancers is part of the McGill Division of Thoracic Surgery and is based at the Montreal General Hospital, part of the
McGill University Health Centre (MUHC).
The Program for Innovative Therapeutics in Chest and Esophago-Gastric Cancers is committed to developing and bringing patients the latest in cancer treatment options. As one of the largest thoracic surgical oncology programs in North America, our team delivers cutting-edge care to patients suffering from lung, esophagus, and stomach cancers, from Montreal as well as regions across Quebec and Eastern Canada.
Surgery for these diseases within the McGill Health Administrative Region covering over 50% of the Province is conducted solely at the Montreal General Hospital, however the McGill Division of Thoracic Surgery partners closely with medical oncology and radiation oncology services in the Cedars Cancer Centre at the MUHC Glen site as well as the Jewish General Hospital and numerous hospitals across Montreal and Quebec.